Note: Descriptions are shown in the official language in which they were submitted.
CA 02370364 2001-11-20
WO 00/72806 PCT/IL00/00294
SUNSCREEN COMPOSITION CONTAINING SOL-GEL MICROCAPSULES
FIELD OF THE INVENTION
The present invention generally relates to safe and stable sunscreen
compositions.
More specifically the present invention relates to sunscreen composition
comprising
of at least one sunscreen active ingredient in the form of an inert sol-gel
microcapsules encapsulating UVB and/or UVA sunscreen compounds (ultraviolet
absorbers), in any acceptable cosmetic vehicle. The composition according to
the
present invention can comprise several ultraviolet absorbers that may be
encapsulated
in the same sol-gel microcapsule or in different capsules. The encapsulation
of the
ultraviolet absorbers makes the composition safer for use, since the
encapsulating
sol-gel material forms a barrier that reduces or even prevents the contact
between the
sunscreen compounds and the human tissue. Hence, various adverse effects that
are
associated with the use of sunscreens, such as photoallergy and phototoxicity
are
prevented. Furthermore, the encapsulation reduces or even prevents cross
reactivity
between different sunscreen compounds when more than one such compound is
present in the composition, between the sunscreen compounds and the packaging
material and between the sunscreen compounds and any other component present
in
the composition. The present invention facilitates an easy incorporation of
the
composite sol-gel encapsulated sunscreen in all types of cosmetic vehicles
including
oil free compositions, with no necessary steps of heating or high shear
forces.
BACKGROUND OF THE INVENTION
Sunscreens compositions are chemical compositions, which are usually applied
topically to skin and hair in order to protect them from the damaging effects
of the
sun's radiation, especially against ultraviolet (UV) radiation.
The damaging effects of sunlight exposure on skin and hair are well
documented.
These effects include increased incidence of skin carcinogenesis,
pigmentation,
anomalies and precancerous lesions such as actinic keratosis, melanoma and
nonmelanoma skin cancers, as well as accelerated skin aging and undesirable
changes
in hair quality. In recent years, a growing number of studies show that damage
is
CA 02370364 2001-11-20
WO 00/72806 PCT/IL00/00294
caused not only by the UVB irradiation (290-320 nm), but also by UVA
irradiation
(320-400 nm).
The use of UV absorbing chemicals for human application is regulated by the
health
authorities. In the US and Australia sunscreens are regulated as over-the-
counter
(OTC) drugs, consequently introduction of new sunscreen active ingredients
requires
heavy investment of time and money. Most of the UV absorbing agents allowed
for
use are UVB absorbers. These include para amino benzoates, salicylates,
cinnamates,
anthranilate, camphors and miscellaneous chemicals. The number of UVA
absorbers
is more limited. with benzophenones (UVB and UVA absorber) and
dibenzoylmethanes (UVA absorber) being the most widely used.
Some of the sunscreen active ingredients have been found to cause photoallergy
and
photosensitization reactions. encouraging the manufacturers to avoid using
them. For
example, growing public awareness to the photosensitization reactions of PABA
and
its derivatives has encouraged the use of PABA free products (see S. Schauder
and H.
Ippen, European LTV Sunfilters, Conference Proceedings, Paris 17-18 November
1998, p. 14). The production of another sunscreen. 4-isopropyl dibenzoyl
methane
was ceased in 1993 due to the high number of photoallergy incidents reported
for this
active ingredient (Ibid). Moreover, some of the reported cases of adverse
reactions to
sunscreen active ingredients relate the adverse reactions to cross reactivity
of several
sunscreen ingredients. as in the case of cross sensitization between different
cinnamate derivatives (Ibid). Moreover, several research groups have
demonstrated
the photoinduced DNA damage and phototoxicity of several sunscreen agents,
including Padimate-O (Knowland et al, FEBS Letters. 324, 309-313. 1993),
Phenylbenzimidazole sulfonic acid (C. Stevenson and R.J.H. Davies, Chem. Res.
Toxicol, 12. 38-45, 1999). Physical sunscreens like titanium dioxide are known
to be
photocatalyst capable of rupturing covalent bonds (U Stafford, K.A. Gray and
P.V.
Kamat, Heterogeneous Chem Rev. 3, 77-104. 1996), and have been shown to
produce
reactive oxygen species under illumination (W.C. Dunlap et al. Int. J.
Cosmetic. Sci.
20, 1-18. 1998).
With the growing demand for higher SPF values and for broad-spectrum
protection,
manufacturers are forced to combine several active ingredients at increased
concentrations (often the maximum permitted concentrations). hence the problem
of
cross reactivity between sunscreen active ingredients is becoming more severe.
An
1~~5=20~0~~ PCTfIL,40/00294
CA 02370364 2001-11-20 p~NDED PCT/IL00/40294
example for cross reactivity effects is the photoinduced interaction between
butyl
methoxydibenzoylmethane (also known as 4,4'-methoxy-t-butyldibenzoylmethane
or B1V~BIVI), an excellent UVA absorber, with the most widely used UVB
absorber
octyl methoxycinnamate (R.M. Sayre et. al, 26~' Annual Meeting if the American
Society for Photobiology, Abstr. No. SPM-A7). This cross reactivity
contributes
significantly to the photochemical instability of both the UVB and the UVA
active
ingredients. Another problem associated with BMDMB that presents a number of
composition problem, is its tendency to react with active methylene groups
such as
those present in formaldehyde releasing preservatives at temperatures above
30°C,
thus restricting the use of such preservatives (W. Johncock, Sun Protection
The
Influencing Factors in Creating Effective Products, March 1999 London, March
1999
and references therein).
Another problem, associated with the use of high sunscreen compounds
concentrations, is the tendency of some of these ingredients to crystallize at
certain
pH range, or if the amount of oil in the composition is not sufficient.
Yet, another problematic aspect in sunscreen products is the selection of
packaging
material. Liquid UVB filters permeate into various plastic packaging materials
(polystyrene as one example), and consequently cause decomposition or
coloration of
the packaging materials. UV absorbing liquids are able to permeate polymers
like
polystyrene, low density polyethylene and polyethylene terphthalate. This can
cause
fracturing of the packaging material, unacceptable colouring of white
packaging
material with time, and assay problems such as ensuring that the proper
content of
active ingredient in maintained upon storage.
Encapsulation of the active sunscreen material within sol-gel capsules can
alleviate
the above-mentioned problems.
Various attempts were made to prepare particles including sunscreen active
ingredients. U.S. Patent No. 5500223 discloses an encapsulation process useful
to
enclose hydrophobic materials within a shell formed of silica colloids. The
particles
obtained by this method are large and therefore not ideal for cosmetic
application. The
primary p is es o ame y ge a ion o a si ica co of s are oo porous an agi a
to protect the encapsulated ingredient. For practical purposes they are
further coated
to obtain much larger particles (few hundred microns) and as such they are not
ideal
3
.Pr~ri~ed 2~ :ab,20012
~~~r~
.,
F r-~ ~ ,~, :, .~ r"'.? n r~" 9 .r,R , s~' ~, .~~
s o5-~ooa ~ PcTi~r..oo~oo~s~ ' ~~sc~e
..,~,~~..~:~. ~..» ~ ~~ CA 02370364 2001-11-20 ,...b. , ..~ ...~.,.,. r...
.....~~.~- "_."z~". .':_..
AMENDED PCT/ILOO100294
for cosmetic application. Moreover, this process is designed to allow slow
release of
the contents of the particles into the surrounding material, which is not
desirable in
sunscreen applications. Japanese Patents 2002867 and 2551240 disclose
rnicrocapsules of sunscreen active ingredients, wherein the sunscreen active
ingredients are included in fine particles being mainly composed of silica.
These two
patents require the active ingredient be solubilized in water, which highly
limits their
application. The loading of active ingredient achieved in these two patents is
only
IS-20%. JP9235217 discloses inorganic sunscreen particles coated with a layer
of
silica. WO 98/31333 discloses sunscreen-doped sol-gel materials, in which the
sunscreen molecules are trapped within a matrix. The low level of active
ingredient
loaded, limits the application of this technique to products having a low
sunscreen
protection factor.
In the present invention it has been found that if the sunscreen active
ingredients are
introduced into the cosmetic vehicle in the form of sol-gel encapsulated
sunscreen,
cross reactivity of sunscreen active ingredients, e.g. butyl
methoxydibenzoylinethane
and octyl methoxycinnamate, can be reduced or even prevented. The separate
encapsulation of sunscreen active ingredients in the sol-gel derived capsules
creates a
barrier that prevents cross interactions between these active ingredients.
Furthermore,
the encapsulation of UV absorbing liquids in sol-gel derived capsules reduces
the
contact between these liquids and the packaging material. Consequently, the
problem
of adverse reactions caused following permeation of the sunscreen active
ingredients
into the packaging material is diminished. Furthermore, the use of sol-gel
encapsulated sunscreens facilitate the incorporation, in the same composition,
of
several components that are incompatible when simply dissolved in the
composition,
for example 2-phenyl benzimidizole-5-sulfonic acid with a or [3 hydroxy acids.
The
present invention also allows easy incorporation of solid sunscreen active
ingredient
or active ingredients that tend to precipitate in various composition, since
even in a
situation that solid is formed, the crystals are confined within the sol-gel
capsules,
hence pleasant non gritty feel and efficient spreading are maintained. Yet
another
advantage of the present invention is the ability to control the
y op ici y rop o icity c aracter y c oosmg a suita a so -ge encaps aring
material, thus the encapsulated sunscreen can be conveniently introduced into
the
composition.
4
P~r~Ied ~ ~ -~
... , . . . __.... . ~~;;~i,~ ~-..
..~ F ~ w,, 2t w. '~'r t .K ~.T. ~~ ~. 'F"'r "~ 3 $
~'~6~05 '2Dfll~-~ PCT/ILflO/00294 . DESC ~~
Y~ 1
'''"~"'~."'."°''~'' CA 02370364 2001-11-20 "'~''°
"°.°q'"~°"'~"~''°'""'" ..
AMENDED PCT/IL00/00294
It is an object of the present invention to provide safer sunscreen
compositions by
reducing or even preventing the contact of the light absorbing molecules
(sunscreen
compounds), or their possible light-induced degradation products, with the
human
tissue.
It is another object of this invention to provide a , stable and safer
sunscreen
compositions by reducing or even preventing cross reactivity between various
ingredients present in the same composition.
It is a further object of this invention to reduce or even to prevent the
deleterious
permeation of sunscreen active ingredient into plastic packaging materials
which may
result in fracturing of the packaging material, unacceptable colouring of
white
packaging material with time, and assay problems. .
It is a further object of this invention to provide the formulator with an
easy-to-use
sunscreen active ingredients, which can be incorporated easily, without
applying heat
or high shear forces, in any cosmetically accepted vehicle.
Yet it is another object of the present invention to provide an easy
incorporation of
solid sunscreen active ingredient or of active ingredients that tend to
precipitate, in
various compositions, thus to maintain a pleasant non gritty feel and
efficient
spreading.
The compositions revealed by this invention are of general nature, and the
method
according to which they are prepared is applicable to any sunscreen compounds
currently used, as well as to sunscreen compounds that will be introduced in
the
future. It is also applicable for other compounds that are regularly used in
cosmetic
compositions. Furthermore, because of the easy incorporation of the sunscreen
active
ingredients and the ability to control their hydrophilicity/hydrophobicity
character and
the capsules size, the cosmetic vehicle to be used with the sunscreen active
ingredients is not limited to any group and can be any cosmetically acceptable
vehicle.
In the context of the present invention the term "sunscreen compound" refers
to an
ultraviolet (L1VA andlor UVB) absorbing chemical that can be used in sunscreen
composition.
In the context of the present invention the term "sol-gel microcapsule"
relates to a
core material which is coated by a sol-gel coating shell.
~prtnted 2'1 ~0~ z .-.~.r-;, _
' .. ~. . r.~~,~,.,~~J =.
x'~~"tl~'k~'x~r" ~xr-
PCTlIL.-00l00294'
.....~. . ~ ,_~ __.. ...
CA 02370364 2001-11-20
AMENDED PCT/IL00/00294
In the context of the present invention the term "sunscreen active ingredient"
refers to
sol-gel microcapsules wherein the core material is a sunscreen compound.
SUMMARY OF THE INVENTION
The present invention relates to sunscreen composition comprising as an active
ingredient sol-gel derived microcapsules that encapsulate ultraviolet (LTV)
absorbing
compounds and any cosmetically acceptable vehicle. The encapsulation of the UV
absorbers forms a barrier between them and the human tissue, as well as
between
them and the other ingredients present in the formula and with the container
in which
the product is contained. The present invention further relates to sunscreen
compositions in which cross reactivity between different sunscreen compounds,
present in the same composition, is reduced or even prevented.
Said sunscreen active ingredient in the form of sol-gel microcapsules, is
prepared by
the method disclosed in US patent application No. 09/372,176. The size of the
microcapsules obtained by this method can be controlled to the range 0.01 -
10012,
preferably 0.1 - IOp., by selecting suitable reaction condition. The
hydophobicity/hydrophilicity character of the sol-gel microcapsules can be
controlled
by selecting suitable sol-gel precursors and suitable reaction conditions and
can be
chosen to be compatible with the cosmetic vehicle to be used in the sunscreen
composition, therefore said microcapsules can be incorporated easily into any
acceptable cosmetic vehicle. The sunscreen active ingredient can be
incorporated into
the cosmetic vehicle in the form of an aqueous suspension of the sol-gel
particles, or
as a dried sol-gel powder. In a preferred embodiment of this invention, the
sol-gel
derived capsule materials consist of the encapsulated matter and silica or
organically
modified silica, in particular methyl modified silica.
The sunscreen compound can be selected from any acceptable UVA absorber or UVB
absorber or combination thereof.
The compositions of the present invention can comprise a single active
ingredient in
the form of sol-ael microca_psules that encapsulate a single sunscreen
compound or
several sunscreen compounds together, or a combination of said active
ingredients, to
obtain a composition with the desired UV absorption spectrum. The
concentration
ratio of the active sunscreen ingredients present at the same composition is
not limited
6
P~r~nted 21 ~=05 20 -' -. r
_. . ~ ~~-1,~r''- '-i-~ i.. 9
,"~,~~iJ '
~ ,~"p 3x°,~~ s.-rTi,rS~5~5- a ~i 3 »a'~'- ~ e~~s '"t<;;g r~%
a~~~ ~~;_ -~,~ PCT/IL00/00294:
CA 02370364 2001-11-20
AMENDED PCT/IL00/00294
and can be of any value. The sunscreen compositions according to the present
invention can comprise about 1 to about 80wt.%, in particular from about 10 to
about
SOwt% (weight percent of the final composition), water suspension of sol-gel
derived
capsules, in any cosmetically acceptable vehicle, or can comprise about 1 to
about
40wt.%, in particular from about 5 to about 25wt.% dry powder of sol-gel
capsules, in
any cosmetically acceptable vehicle.
The present invention further relates to the sol-gel microcapsules
encapsulating
sunscreen compound for use as sunscreen active ingredient in sunscreen
compositions. Said sunscreen active ingredient can be added to the cosmetic
compositions at the end of the composition process, without the application of
heat or
shear forces. However, such steps of composition may 'be carried out if
required for
the purpose of formulating other constituents of the composition. The
sunscreen
active ingredient can be incorporated in any cosmetically acceptable oil-in-
water or
water-in-oil compositions; the final product may take the form of an oil, a
gel, a solid
stick, a lotion, a cream, a mills, an aerosol, a spray, a powder, a foam, a
shampoo, a
hair conditioner or lacquer or a make-up.
The compositions according to the present invention are of general nature, and
applicable to any sunscreen compounds currently used, ~as well as to compounds
that
will be introduced in the future. It is also applicable for other active
ingredients that
are regularly used in cosmetic compositions.
BRIEF DESCRIPTION OF THE DRAWINGS
Figure 1 is a graph of a supercoiled DNA remaining as a function of
irradiation time
with respect to some samples.
7
ef'r~r~ted 2'~ .05 ' ~.~t~._ r.
. , ;L'y'jj ...
w.:_ ~ #~.F'~..'g~z' ~'x~ ~~~t: r ~ s~.''wr"~"~'st'~c~~'~i S.~r" - ~~"~_..
~~~ 6~fl5~2001 P~T~1L00,~002~9~~ DESC e~~~~,
CA 02370364 2001-11-20
AMENDED PCTlIL00/00294
DETAILED DESCRIPTION OF THE INVENTION
The present invention relates to stable and safer sunscreen compositions in
which the
contact between the sunscreen compounds and the human tissue, and the
reactivity
between sunscreen compound and other components present in the composition are
reduced or even prevented, by encapsulation the sunscreen compounds in a sol-
gel
derived microcapsules. The selection of the cosmetic vehicle to be used in the
composition is not limited and can be any cosmetically acceptable vehicle. The
encapsulated sunscreen compounds can be incorporated into the cosmetic vehicle
in
the form of an aqueous suspension of the sol-gel particles, or as a dried sol-
gel
powder.
Said sol-gel microcapsules are prepared by the method disclosed in US patent
application No. 09/372,176, i.e., by a) emulsifying hydrophobic solution
comprising sol-gel precursors and at least one ultraviolet absorber in an
aqueous
solution under high shear forces and b) mixing and stirring the obtained
emulsion
with a second aqueous solution at a suitably selected pH to obtain the sol-gel
microcapsules. The size of the microcapsules so obtained can be controlled to
the
range 0.01 - 100, preferably 0.1 - 10~, by selecting suitable reaction
condition.
The sol-gel precursors can be selected from metal or semi-metal alkoxide
monomers,
or metal ester monomers, or semi-metal ester monomers or monomers of the
formula
M(R)"(P)m, wherein M is a metallic or semi metallic element, R is a
hydrolyzable
substituent, n is an integer from 2 to 6, P is a non polymerizable substituent
and m is
and integer from 0 to 6, or partially hydrolyzed and partially condensed
polymer
thereof, or any mixture thereof.
In a preferred embodiment of this invention, the sol-gel microcapsules are
silica or
organically modified silica microcapsules, produced through the sol-gel
process
disclosed in US Patent application no. 09!372,176. The term "organically
modified
silica microcapsules" refers to sol-gel microcapsules which are obtained when
the
sol-gel precursors are of the formula M(R)n(P)m, wherein M is Si R is a
hydrolyzable
substituent, n is an integer from 2 to 5, P is a non polymerizable substituent
and m is
and integer from 1 to 6.
8
Prt~~~d 2;1 0~ 20~3'f. ~' ~
~1 fi~02fl0~~PCT/lL.i~~/0029k4,~ $flESC~ r~~~ ':
~~~'~'"''~"~°'~" ' CA 02370364 2001-11-20
AMENDED PCTIIL00100294
Since the encapsulation process is general, the capsules may contain various
sunscreen compounds or their mixtures.
The hydrophilicity/hydrophobicity character of the capsules is determined by
the
encapsulating material, and not by the sunscreen compound which is
encapsulated
inside it. Hence, lypophilic sunscreen compounds, which normally can be
dissolved
only in hydrophobic, fat containing phases, are easily incorporated in the
aqueous
phase of any composition, be it o/w {oil in water) or w/o (water in oil)
emulsions, or
in oil-free compositions, e.g. gels. '
The compositions according to the present invention can comprise a hydrophilic
composition as the cosmetic vehicle and water, dispersible microcapsules
encapsulating sunscreen compounds that are hydrophobic, water-insoluble.
The invention further reveals that one or more sunscreen active ingredients
are
confined within particles of specific particle size, which is independent of
the
cosmetic vehicle, the composition preparation method,~or the sunscreen
concentration.
This confinement prevents the rough feel and decreased coverage which are
associated with undesired crystallization of sunscreen compounds, since in the
event
of crystallization the crystals are confined within the capsules, consequently
the
pleasant feel and efficient coverage are maintained.
The aqueous suspensions of encapsulated sunscreens compounds may contain 1 to
50% .wt. sunscreen compounds (a single sunscreen compound, or a combination of
several sunscreens compounds together). In a preferred embodiment, the aqueous
suspensions contain 20 to 40% wt. sunscreen compounds. The dried sol-gel
silica
powder may contain 1 to 85% wt. sunscreen compounds. In a preferred
embodiment,
the dried sol-gel silica powders contain 50 to 80% wt. Sunscreen compound.
The skilled formulator may use a suitable concentration of the aqueous
suspension or
the powder, to obtain the desired concentration of each sunscreen ingredient
in the
final composition. Thus, a cosmetic screening composition is obtained, which
comprises in a cosmetically acceptable vehicle, about 1 to about 80%, in
particular
from about 10 to about 50% (w/w of the final composition) water suspension of
the
sol-gel derived capsules. In the same manner, a cosmetically acceptable
screening
composition may be obtained, comprising about 1 to about 40%, in particular
from
9
. Fr~nteci 21-0 F ~ ~~ ~~--t
,. . . t~~o_ ,J ~a~ f 4 c ,..
x :;n~'in...,o; ' '~' ' r .xtr ~.s"
PCT/ILCI~/fl029,4'
DESK '~'
.Li:~>._ .... s.,s,:::.;a.a".,,....v:~T r~:-~...> ..~.." ... .~.. ... ~s~
CA 02370364 2001-11-20
AMENDED PCT/IL00/00294
about 5 to about 25% (w/w of the final composition) dry powder of sol-gel
derived
capsules.
The sol-gel containing suspension can easily be combined with o/w compositions
at
the end of the composition, by simple mixing or stirring with any suitable
mixer or
stirrer. No steps of heating or high shear force mixing are required in order
to achieve
good mixing. Nonetheless, the encapsulating material, being inert and stable,
can
sustain high shear forces such as those active in a homogenizer (Ultra Torax
for
example) and can sustain heating to 70°C for the typical time used in
composition (up
to 60 minutes), without any deterioration in the encapsulation or the capsules
properties. Hence, if such processes are required for obtaining the desired
formula, the
aqueous suspension of the sol-gel derived sunscreen capsules can endure these
processes.
If w/o composition is prepared, the aqueous suspension is easily incorporated
in the
water phase by simple mixing or stirring. The combined water phases can then
be
handled as desired in a normal composition procedure known to the skilled
formulator. '
In all these cases, several aqueous suspensions of sol-gel derived capsules
containing
different sunscreen active ingredients may be added together at any of these
stages, in
orderto obtain formulae that contain several active ingredients in separate
capsules, to
reduce or even to prevent their cross reactivity.
The sol-gel dried powder can also be easily combined with wlo compositions at
the
end of the composition, by simple mixing or stirnng with any suitable mixer or
stirrer.
High shear forces may be applied to facilitate fast and efficient mixing of
the powder
in the cosmetic vehicle. Also, the powder may be re-suspended in the aqueous
phase
prior to mixing the composition to ease efficient dispersion. The inert nature
and
stability of the sol-gel derived capsules allows the formulator to utilize
these tools
without damaging the encapsulation or the capsules properties.
The ease of composition when utilizing the sol-gel derived capsules is a
unique
advantage of this invention, and is an essential part of the innovation
disclosed here.
Therefore, the composite encapsulated sunscreen active ingredient can be
incorporated in cosmetically acceptable oil-in-water or water-in-oil
compositions; the
final product may take the form of an oil, a gel, a solid stick, a lotion, a
cream, a milk,
Y
x~ ~~ ~'v ~l4af r~~~~ ~ ~ ..
~~x"' ~i,~T ~!"~ xx'~: ,~-,fix f ; s~ ~scwy~,# ~'~e'~.'.,~=;.'~ ~ , ~ t
'°t. i.-"'m~'w3t"'Lk
.=~~s o~ ~oo~:PcTi~~:oo~oo~s4: oESC~-~:~.~--
Y5J13wkn..v ' rh5:eu.t$ °1N.,.a .:3 .._,''1~e~2i'~.. #3c"1'4 b:,.~.:
CA 02370364 2001-11-20
AMENDED PCT/IL00/00294
an aerosol, a spray, a powder, a foam, a shampoo, a hair conditioner or
lacquer or a
make-up. The composite encapsulated sunscreen active ingredient can be added
to the
cosmetic compositions at the end of the composition process, without the
application
of heat or shear forces. However, such steps of composition may be carried out
if
required for the purpose of formulating other constituents of the composition.
It is further demonstrated and emphasized in the case of sunscreen active
ingredients,
which are solid in nature, or tend to form crystals if the composition is not
carefully
balanced. Some examples of such active ingredient include benzophenones,
dibenzoylmethanes, camphor and phenyl benzimidazole sulfonic acid in the
presence
of a and ~ hydroxy acids. The encapsulation process confines these active
ingredients, even in the event of crystallization, within the capsules.
Consequently, the
problems normally associated with crystals formation, l. e. rough feel and
poor
coverage, are prevented.
The particle size of the capsules is determined in the encapsulation process,
consequently it does not change as a result of the formula or the material
encapsulated
inside it, even in the event of crystal formation.
An important feature of the capsules is their very efficient encapsulation of
the
lypophilic sunscreen compounds, which reduces or even prevents their leaching
out
into aqueous phases and into a large number of cosmetically acceptable oils.
Thus,
incorporation of incompatible active ingredients when each of them is
encapsulated
separately in the sol-gel capsules is a very efficient method to reduce or
even to
prevent their cross reactivity.
Another important objective of this invention is to provide safer sunscreen
products.
As discussed in the background of this invention, several research groups
around the
world have demonstrated the potentially harmful effects of several sunscreen
products
on several in vitro models. It is also recognized that with the increased use
of
sunscreen product in the world, a growing number of incidents of photoallergy
are
being reported. In fact, some sunscreen products that are allowed for use by
the
regulations have been practically withdrawn from the market due to the high
number
,
W Sunfilters, Conference Proceedings, Paris 17-18 November 1998, p. 14). With
the
encapsulated products, the contact between the active sunscreen molecules or
its
11
r
Printed 21,=D5 2Q0~ ~ _ :":~ '; ;~.
, ,...... ,.. " _. ....,. ~~~..v~~~y ~. .,....
PCT>IL~0~0~~94
CA 02370364 2001-11-20 ENDED PCTIIL00/00294
photdegradation products and the human tissue is eliminated. Consequently the
harmful potential of the sunscreen active ingredients is dramatically
minimized.
It is a further object of this invention to provide a screening composition
which
reduces or even prevents the penetration by diffusion of sunscreen active
ingredient
into plastic containers, which may result in fracturing of the packaging
material,
unacceptable colouring of white packaging material with time, and assay
problems.
It has also been found that utilizing the encapsulated sol-gel sunscreen,
active
ingredients that form crystals in regular compositions can be easily used, as
even in
the event of crystallization the crystals are confined within the capsule,
hence pleasant
feel and efficient coverage are maintained.
The sunscreen compound can be selected from the group consisting of 2-
ethylhexyl
4-methoxycinnamate, 4-aminobenzoic acid, 2-ethylhexyl-
N,N-dimethyl-4-aminobenzoate, 2-cyano-3,3-diphenylacrylic acid 2-ethylhexyl
ester
(Octocrylene), 2-hydroxy-4-methoxy-benzophenone (Oxybenzone)
2-phenylbenzimidizole-5-sulfonic acid, 3,3,5-trimethyl-cyclohexyl-salicilate
(Homosalate) octyl salycilate, 4,4'-methoxy-t-butyldibenzoylmethane, 4-
isopropyl
dibenzoylmethane, 3-(4-methylbenzyledene) camphor, 3-benzylidene camphor,
triethanolamine salicylate, 4-N,N-(2-ethylhexyl)methyl aminobenzoic acid ester
of
2,4-dihydroxybenzophenone, 4-N,N-(2-ethylhexyl)methyl aminobenzoic acid ester
of
4-hydroxydibenzoylmethane, 4-N,N-(2-ethylhexyl)methyl aminobenzoic acid ester
of
2-hydroxy-4-(2-hydroxyethoxy)benzophenone, 4-N,N-(2-ethylhexyl)methyl
aminobenzoic acid ester of 4-(2-hydroxyethoxy)dibenzoylmethane and mixtures
thereof.
A sunscreen composition according to claim 1 wherein the sunscreen active
ingredient
is in the form of a dried sol-gel powder.
The cosmetic vehicle according to the present invention can be selected from
the
group consisting of fatty alcohols, fatty acids, fatty acids esters, fatty
acid
triglycerides, lanolin, natural or synthetic oils and waxes, water in oil and
oil in water
emulsions.
The sunscreen composition cam further compnse cosmetic a ~uvants se ecte om
thickeners, emollients, emulsifiers, humectants, surfactants, film forming
agents,
12
_~'r~rrf~d.2~=05' 20~i ~ t"
~#r,.~~l',~::~ ~i'~~
:.- . ~ ~ .:.. %r~~.:t=
~~'~~_p~~p~PCTlILDOJ'0~ 94~DESC,. .~:
;,. ..
CA 02370364 2001-11-20 ENDED PCT/IL00/00294
preservatives, antifoaming agents, fragrances, lower monoalcoholic polyols,
propellants, colorants and pigments.
The sunscreen composition according to the present invention can further
contain
additives selected from the group consisting of sunscreen actives, sunless
tanning
actives, skin lightening actives anti-acne actives, anti-skin wrinkling
actives, vitamins,
nonsteroidal anti-inflammatory actives, anesthetic actives, anti-pruritic
actives,
anti-microbial actives, and mixtures thereof wherein said additives are either
dissolved in the cosmetic vehicle or are also in the form of sol-gel
microcapsules.
The sunscreen composition according to the present invention can further
comprise
physical sunblock active ingredients selected from the group consisting of
titanium
dioxide, zinc oxide, iron oxide, and mixtures thereof wherein said physical
sunblock
ingredients can be of any commercially available grade, including surface
treated
particles such as titanium dioxide, which has been surface treated with
silica, alumina,
stearic acid or mixtures thereof, or any other surface treatment.
The sunscreen composition according to the present invention can further
comprises
a or (3-hydroxy acids such as salycilic acid, glycolic acid, lactic acid,
retinoic acid
and mixtures thereof.
The present invention further relates to sol-gel microcapsules encapsulating
at least
one sunscreen compound for use as a sunscreen active ingredient in sunscreen
products by easy incorporation into any cosmetically acceptable vehicle
without the
use of any shear forces.
Following are preferred embodiments for said sol-gel microcapsules:
(a) Sol-gel microcapsules encapsulating 2-ethylhexyl 4-methoxycinnamate, as
well
as other cinnamate derivatives such as isopentyl 4-methoxycinnamate,
diethanolamine methoxycinnamate, 2-ethoxyethyi-4-methoxycinnamate and
mixtures thereof.
{b) Sol-gel microcapsules encapsulating Oxybenzone (benzophenone-3), as well
as
other benzophenone derivatives such as benzophenone-4, benzophenone-8,
benzophenone-1, benzophenone-2, benzophenone-5, benzophenone-9 and
mixtures thereof.
13
.i-f V 13 L.li ..
PCTIIL~D0100294DESC~~=~ ~~ ry
CA 02370364 2001-11-20 ENDED PCT/IL00/00294
(c) Sol-gel microcapsules co-encapsulating 2-ethylhexyl 4-methoxycinnamate and
oxybnezone, as well as as other cinnamate derivatives such as in preferred
embodiment (a) and other benzophenone derivatives such as in preferred
embodiment (b) and mixtures thereof.
(d) Sol-gel microcapsules co-encapsulating Homosalate and
4,4'-methoxy-t-butyldibenzoylmethane, as well as other derivatives of
salicylate
such as octyl salycilate, 4-isopropylbenzyl salicylate~ and dibenzoylmethanes
such
as isopropyl dibenzoyl methane and mixtures thereof.
(e) Sol-gel microcapsules co-encapsulating Homosalate and
4,4'-methoxy-t-butyldibenzoylmethane and a suitable cosmetic oil such as
Capric/caprylic triglyceride, octyl palmitate, C12-CIS alkyl benzoate, dioctyl
maleate, propylene glycol dicaprylate/dicaprate, diisopropyl adipate, hexyl
laurate,
and mixtures thereof, as well as other derivatives of salicylate and
dibenzoylmethanes such as in claim 21 and mixtures 'thereof.
(f) Sol-gel microcapsules co-encapsulating 2-cyano-3,3-diphenylacrylic acid
2-ethylhexyl ester (Octocrylene), and 4,4'-methoxy-t-butyldibenzoylmethane, as
well as other derivatives of dibenzoylmethane such as
isopropyldibenzoylinethane
and mixtures thereof.
(g) Sol-gel microcapsules co-encapsulating 2-cyano-3,3-diphenylacrylic acid
2-ethylhexyl ester (Octocrylene) and 4,4'-methoxy-t-butyldibenzoylmethane and
a
suitable cosmetic oil such as Capric/caprylic triglyceride, octyl palmitate,
CI2-CIS alkyl benzoate, dioctyl maleate, propylene glycol
dicaprylate/dicaprate,
diisopropyls adipate, hexyl laurate, and mixtures thereof, as well as other
derivatives of dibenzoylmethane such as isopropyl dibenzoylmethane and
mixtures thereof.
(h) Sol-gel microcapsules co-encapsulating Homosalate and
3-(4-methylbenzyledene) camphor, as well as other derivatives of salicylate
such
as octyl salicylate, 4-isopropylbenzy! salicylate arid other camphor
derivatives
such as 3-benzylidene camphor and mixtures thereof.
(i) Sol-gel microcapsules co-encapsulating Homosalate and
3-(4-methylbenzyledene) camphor and a suitable cosmetic oil such as
Capric/caprylic triglyceride, octyl palmitate, C 12-C 1 S allcyl benzoate,
Dioctyl
14
~'r~~t~cl 2'1 ~~5 2t3~1
.. . .. ~ . .
y~~a.2N~'=.~' ~:,.~"' '~'~.~s'~ rr~ r s n.ycp',~"~~='t~t..x
e1 fi 05 2001 ~ RCT1ILF~a301002~4.
...=:~;X, r .~ -
CA 02370364 2001-11-20
AMENDED PCT/IL00/00294
maleate, propylene glycol dicaprylate/dicaprate, diisopropyl adipate, hexyl
laurate,
and mixtures thereof, as well as other derivatives of salicylate such as octyl
salicylate, 4-isopropylbenzyl salicylate and other camphor derivatives such as
3-benzylidene camphor and mixtures thereof.
(j) Sol-gel microcapsules encapsulating 2-ethylhexyl
N,N-dimethyl-p-aminobenzoate, as well as other aminobenzoic acid derivatives
such as 4-aminobenzoic acid (PABA), glyceril amionobenzoate, menthyl
anthranilate, ethyl PABA, amyl dimethyl PABA and mixtures thereof.
The sunscreen composition according to the present invention can comprise any
of the
preferred embodiment (a) to (j) or a combination thereof in any acceptable
cosmetic
vehicle. Following are preferred embodiments of sunscreen compositions
according
to the present invention:
(k) A sunscreen composition comprising of preferred embodiments (a) and (d) in
any
acceptable cosmetic vehicle
(1) A sunscreen composition comprising of preferred embodiments (a) and (e) in
any
acceptable cosmetic vehicle
(m) A sunscreen composition comprising of preferred embodiments (a) and sol-
gel
microcapasules encapsulating cinoxate in any acceptable cosmetic vehicle.
The compositions revealed by this invention are of general nature, and the
method
according to which they are prepared is applicable to any sunscreen compounds
currently used, as well as to sunscreen compounds that will be introduced in
the
future. It is also applicable for other compounds that are regularly used in
cosmetic
compositions. Furthermore, because of the easy incorporation of the sunscreen
active
ingredients and the ability to control their hydrophilicity/hydrophobicity
character and
the capsules size, the cosmetic vehicle to be used with the sunscreen active
ingredients is not limited to any group and can be any cosmetically acceptable
P~fipteci 2'~ ~5 ~~~3~ ~n ~ ~ r ='~ ' ;: ~~ ~~-~ '°
,.. :._ .. , . . . . _.. , . r''~~"
em n ~.rt'.Yg=- '~"as'~ "i.'"a r~tr r, s i~ ~.s'~ a a'?~' .V
~t~ s ~ o~ 200~~ ,' PCTlnooloo294
CA 02370364 2001-11-20 ~TJDED PCT/IL00/00294
EXAMPLES
The following examples clarify and demonstrate the invention and are not under
any
circumstances exclusive. All percentage data is given in weight percentage
(w/w}
unless specified otherwise.
Example 1: co-encapsulation Homosalate (HMS) and butyl methoxydibenzoylmethane
BMDBM
12.85g BMDBM was dissolved in 38g HMS. The obtained mixture was dissolved in
51.4 tetraethoxysilane (TEOS) and the organic phase was emulsified in 240g of
aqueous solution containing 1% cetyltrimethyl ammonium chloride (CTAC) under
high shear forces using an Ultra-Turrax T-25 basic with S 25 KR-18G dispersing
tool
(IKA) at 19,000 rpm. The vessel walls were cooled by immersion in an ice-water
bath
during the homogenizing process. The such obtained emulsion was then poured
into
an IKA LR-A 1000 Laboratory reactor, equipped with Eurostar Power control-visc
P4
stirrer, containing 350 NaOH aqueous solution at pH 11.3. The emulsion was
stirred
at room temperature for 24 hours. The product was precipitated in a centrifuge
at
20,000 g, rinsed by re-suspension in deionized water, precipitated again and
finally
re-suspended in a 1% polyvinyl pyrrolidon (PVP K30, ISP) to afford a stable
dispersion containing 31.3% HMS and 10% BMDBM in the suspension.
The obtained suspension is smooth, pleasant to touch and can be incorporated
into
various cosmetic vehicles to obtain a sunscreen composition useful for
protecting
against ultraviolet radiation.
Example 2: encapsulation of 2-ethvlhexyl p-methoxycinnamate (OMC) in silica
33 g OMC was dissolved in 33g TEOS and the organic phase was treated as
described
in example 1.
The isolated product consisted of an aqueous suspension of silica capsules,
containing
35.8% OMC (wlw in final suspension).
The obtained aqueous suspension is smooth, pleasant to touch and can be
incorporated
into various cosmetic vehicles to obtain a sunscreen composition useful for
protecting
against ultraviolet radiation.
16
k,.:
~'~Pr~nIA.~ 2~ :DS 24(~~h
,~'~ 5; F""s. ~ t'" ~' r t'~.. S . a
. , ... . . . , , , . la., y.~:.)4_i~ ,.,..,
~~ a~.da" r ~;,~"",r~ x ~x . ~ . ~~ ~ ~rr~-~-~
'~~~'~5=20D~;- , P,~T/ILOC1100294;DE~SC~~e.
CA 02370364 2001-11-20
AMENDED PCT/IL00/00294
Example 3 ~ co-encapsulation of Octocrvlene and BMDBM in silica
4.1 g BMDBM was dissolved in 12.4g octocrylene. The obtained mixture was
dissolved in 49.5g TEOS and the organic phase treated as described in example
1.
The isolated product consisted of an aqueous suspension of silica capsules,
containing
23.5% octocrylene and 7.2% BMDBM (w/w in final suspension).
The obtained aqueous suspension is smooth, pleasant to touch and can be
incorporated
into various cosmetic vehicles to obtain a sunscreen composition useful for
protecting
against ultraviolet radiation
Example 4' encapsulation of 2-eth~ihexyl N N-dimethvl-n-aminobenzoate (Pad-07
in
silica
16.5g Pad-O was dissolved in 49.5g TEOS. The obtained mixture was treated as
described in example 1. The isolated product consisted of an aqueous
suspension of
silica capsules, containing 28.5% Pad-O {w/w in final suspension).
The obtained aqueous suspension is smooth, pleasant to touch and can be
incorporated
into various cosmetic vehicles to obtain a sunscreen composition useful for
protecting
against ultraviolet radiation
Example S: encapsulation OMC in methyl modified silica.
2.75g OMC was dissolved in 8.25g methyltriethoxysilane. The organic phase was
emulsified in SOg of aqueous solution containing 1 % ethoxylated sorbitan
monooleate
(Tween-80, ICI). under high shear forces (as described in example 1). The such
obtained emulsion was then poured into SOg stirred ammonia solution (pH 11.2).
The
emulsion is stirred at room temperature for 24 hours, followed by stirring at
50°C for
3 hours. The obtained powder is washed with water and freeze dried to give a
fine
silica powder containing 24% OMC.
The obtained powder is smooth, pleasant to touch and can be incorporated into
various cosmetic vehicles to obtain a sunscreen composition useful for
protecting
ultraviolet radiation
17
,.
~p~nt~d ~.~ :v~ z~oa _
~' t ae E ~d'fi~. ~~ ~, c'~ r ~ ~4~~', ~ ~ea~' ,y . a ~. - '~ ~ T
16;~~-200~1~r PCTJ1L~~D%00294~~S~r,.~ '.:
~'~' '"'~'"°'~'" "°'' CA 02370364 2001-11-20
A1VIENDED PCTIIL00/00294
Examples 6' oil in water composition containing hydrophilic suspension of
encaQsulated sunscreen in silica.
INCI name %wlw
PHASE A
1 Squalane 5.00
2 Cetyl alcohol 2.50
3 Glyceryl stearate & PEG-100 5.00
stearate
4 Propylparabene 0.10
PHASE
B
Aqua (water) 50.20
6 Methylparabene 0.20
7 Disodium EDTA 0.05
8 Imidazolidinyl urea 0.50
PHASE
C
9 Methylchloroisothiazolinone
&
Methylchlorothiazolinone &
Benzyl alcohol 0.05
PHASE D
Silica/OMCBMDBM
(20.6% OMC, 3.8% BMDBM in
the water suspension) 36.40
Phase A was heated to 75°C and mixed. Phase B was heated to
75°C and mixed.
Phase B was poured into phase A and stirred for 5 minutes, followed by 25
minutes
homogenization. The mixture was cooled to 55°C, and phase C was added
while
stirring. The mixture was cooled further to 40°C and phase D was added
while
stirring. The cream was stirred for another 5 minutes.
The obtained composition has an estimated SPF of ~10 (preliminary test on 3
volunteers) and is stable, uniform and pleasant to touch.
18
~r ~ x~~ ~° ,: a
~'1'i~~ed~2'~' 05~200'1~~ . -
".x.ra x,..'~~:.~~ ~ ~s,~y.';~
#~. > ~.
n z.»xe:~,.~.~. i~r:~-"a=._~F
CA 02370364 2001-11-20
AMENDED PCTlIL00/00294
Examples 7~ oil in water composition containing hydrophilic suspension of
encapsulated sunscreen in silica.
INCI name %w/w
PHASE A
1 Paraffinium liquiduim (minral5.00
oil)
2 Decyl oleate 5.00
3 Dimethicone 1.00
4 Cetearyl alcohol 1.00
Glyceryl stearate ~ 3.00
6 Potassium cetyl phosphate 2.00
PHASE
B
7 Aqua (water) 47.25
8 Xanthan gum O.
I
S
9 Propylene glycol 5.00
2-Bromo-2-nitropropane-1,3
diol &
Methylparabne & Phenoxyethanol
&
Propylbarabne 0.50
PHASE C
11 Lactic acid 88% (in water) 0.10
PHASE D
11 Silica/OMC
(25% OMC in the water suspension) 30.00
Phase A was heated to 65°C and mixed. Phase B was heated to
65°C and mixed.
Phase B was cooled, and phase C was added to obtain pH 4.5-4.8. Phase D was
stirred
into phase B. The combined phase was heated again to 65°C and phase A
was stirred
in. The combined mixture was homogenized briefly with a high shear mixer, and
the
composition was stirred until cooled to room temperature.
The obtained composition is stable, uniform and pleasant to touch. The in
vitro SPF
val»P mP~lll p$l~Ign '
19
~. ; ~_
~~:a..a_v
."~,..~~~, .:
CA 02370364 2001-11-20
AMENDED PCT/IL00/00294
Examples 8' water in oil composition containin~~ hydrophilic suspension of
encapsulated sunscreen in silica.
INCI name %w/w
PHASE A
1 Caprylic/Capric triglyceride 9.00
.
2 C12-C15 Alkyl benzoate ~ 7.50
3 Diisostearoyl polyglyceryl-3 3.00
diisostearate
4 Hydrogenated castor oil 0.30
Cera Alba (Beeswax) 0.20
PHASE
B
6 Aqua (water) ' 47.25
7 Magnesium sulfate . 1.00
8 Glycerin , 1.00
9 2-Bromo-2-nitropropane-1,3 diol
&
Methylparabne & Phenoxyethanol
&
Propylbarabne 0.50
PHASE C
11 Lactic acid 88% (in water) 0.10
PHASE D '
12 SilicalOMC '.
(25% OMC in the water suspension) ~. 30.00
Phase A was heated to 70°C and stirred. Phase B was heated to
70°C and stirred.
Phase B was cooled, and phase C was added to obtain pH below 5Ø Phase D was
stirred into phase B. The combined phase was heated again to 70°C and
phase A was
stirred in The mixture was cooled with stirring, and homogenized at
30°C.
The composition is stable, uniform and pleasant to touch. The in vitro SPF
value
measured for this composition is 12.8.
"__0~
.~:~ ;
f'~~ait',S5 sue"" .'~ ~5 b "~ ; .ei a ~~a:~~ ~ ~ :a'~'.~' , k~ f'.~. t,.e
r ~ 0 ~'~~ CA 02370364 2001-11-20 rhGfiT~ILaO/00294~' DES~~~ ~
'ia~,~'~rss "~!, »~2.~~ :L.~.ar..W.s'~~x..~».~~'s.~w~ ._art~~cs:t~t ~a,~ .~-
3,3:
AMENDED PCTIIL00/00294
Examples 9' water in oil composition containing hydrophobic uowder of
encapsulated
OMC in methyl modified silica.
INCI name
PHASE A
1 Caprylic/Capric triglyceride 9.00
2 C 12-C 1'S Alkyl benzoate ~ 7.50
3 Diisostearoyl polyglyceryl-3 3.00
diisostearate
4 Hydrogenated castor oil , 0.30
Cera Alba (Beeswax) . 0.20
PHASE
B
Aqua (water) 65.0
7 Magnesium sulfate 1.00
g Glycerin 1.00
9 2-Bromo-2-nitropropane-1,3 diol
&
Methylparabne & Phenoxyethanol
&
Propylbarabne 0.50
PHASE C
1 Silica/OMC
(60% OMC in the dry powder) 12.5
Phase A was heated to 70°C and stirred. Phase B was heated to
70°C and stirred.
Phase C was added to phase A with stirring. All phases were combined together,
cooled with stirring and homogenized.
21
~'~~t~d'2~ fly Y2~~'1= ~~'
__
~~Li«~~ ~ ~ "
r,.
'L~ =~~,e ~ " ~~~ w~7
s3Fd:rY.~~r3.i~~;.,... .,3 F,.nt:.., ...~.~..>. , ~°.,r.~...:r.
~.~.~.",~a...
CA 02370364 2001-11-20
AMENDED PCTlIL00100294
Example 10' ~hototoxicit~ tests of encapsulated sunscreen compounds versus
free
sunscreen compounds.
The phototoxicity tests are based on the survival of a yeast strain, XD83. A
single
colony of yeast is inoculated into growth medium, and harvested during the
exponential growth. The cells are suspended at a known concentration in a
phosphate
buffer, to afford a uniform population of cells. The cells are illuminated
with
simulated sunlight (13 mW/cm2} in the absence or presence of test compounds
v~~ith
continuous stirring. Samples are taken at increasing times (0, 10, 20, 30
minutes of
illumination). The samples are analyzed semi-quantitatively, by applying two
dilutions of the sample as small droplets (10 p.1) to the surface of nutrient
agar plates,
and incubated at 37°C for 48 hours. Patches of growth are found around
the droplet. It
can be easily seen when growth has been decreased. Sunscreen samples are
introduces
as 1000p.M concentration of the major UVB sunscreen active ingredient.
Padimate-O
and BMDBM are used as positive controls, both showing a strong phototoxic
effect
on the growth of the yeast cell. The results are summarized in table 1.
Table 1: Phototoxicity test results.
Sample Content Phototoxicity
Padimate-O (Positive blank) . Clearly toxic
BMDBM (Positive blank) More toxic than
Padimate-O
Light alone (Blank) Non-toxic
132(I) Encapsulated (OMC + BMDBM)8 Non-toxic
139 Free (OMC + BMDBM)a ~ Toxic about equal to
Padimate-O
135 Blank cream Slightly toxic
a 7.5% OMC, 1.4 BMDBM.
22
:~ F,~~,, -~z -
Prtnt~d'2'1=D~ a20~1 ° ~ .
». . ... , f.4iVt a,. 'teJ6.le
~''3 ~~r,3'~-iF'~ y?.fi~p. "
PCTII LOOOQ29~
CA 02370364 2001-11-20 'v ~ '~~" ' -'"~-'~'~t
AMENDED PCT/IL00/00294
The results show that encapsulation of the sunscreen active ingredients
creates a
barrier between the entrapped sunscreen and its photodegradation products and
the
yeast cells. Consequently, phototxicity is prevented.
Example 11 ' Plasmid DNA nicking tests of encapsulated sunscreen comuounds
versus
free sunscreen compounds.
DNA plasmid nicking assay is outlined in Dunford et al, FEBS lefts 418, 87-90.
The
light source consist of a 250-watt ozone free xenon lamp (Spiers Robertson)
with a
reflector, condensing lens, dichroic mirror to dissipate infra-red irradiation
and a
2-mm Schott WG 320 filter. The total irradiace between 290 and 400 nm is about
5
mW/cm2
2.5 pg of supercoiled plasmid DNA in 50 p1 of 0.01 M sodium phosphate buffer,
pH
7.5, was irradiated in an upturned Eppendorf lid on a brass block embedded in
ice and
~l samples were taken at each time point and kept on ice. They were analyzed
by
electrophoresis on neutral 1% agarose gels (1% wlv agarose, 0.5 TBE, 0.3 pg
ethidium bromide/ml) run in 0.5 TBE buffer in a GNA 100 or GNA 200 gel tanks
(Pharmacia), at 15 V/cm for minigels and 5 v/cm for regular gels, which were
stained
with ethidium bromide, viewed on a 313 nm UV transilluminator and photographed
on a Polaroid b65 positive/negative instant pack film. The number of lesions
per
molecule of DNA was calculated by measuring the intensity of the supercoiled
DNA
by densitometry of the agarose gel negative using a model GS-670 imaging
densitometer (Bio-Rad). When the total amount of damage inflicted on the DNA
is
small the amount of undamaged DNA left after an illumination gives a direct
measure
of the number of strand breaks inflicted. As positive controls Padimate-O and
BMDBM are used (at saturation concentrations). It has been shown that both
these
compounds inflict strand breaks on DNA when they are illuminated in vitro.
The samples, which are o/w emulsions, were added to DNA as suspensions in
buffer,
so as to arrive as a notional concentration of 1000 p,M with respect to the
UVB
absorbing component. As most sunscreen chemicals are virtually insoluble in
water
this ensures that they are present at saturation.
Figure 1 shows that sample 139, in which OMC and BMDBM are present free in the
cosmetic composition, significant damage is inflicted on the DNA, similar to
the
23
fi , x .,
'~~~~' .Y.~.s~~',w,<' "'s''"~ "°~r' ,.
r 16T05' 2~01~~ P;GTlI~0~1.fl0294,. DESC ..~.r_. . .
:~,._ ~. .:.~s~."~ ~ CA 02370364 2001-11-20
AMENDED PCT/IL00/00294
damage inflicted by the BMDBM used as the positive control. Sample 132, in
which
OMC and BMDBM are encapsulated, does not inflict damage on the DNA, and is
similar to plasmid alone, without added chemicals.
It is therefore concluded that encapsulation of sunscreen active ingredients
creates a
barrier not only for the sunscreens but also to their photodegradation
products. This
encapsulation reduces and even prevents the adverse reactions found in the
free
systems, which inflict damage on the DNA.
24
r y;
~~'4;.t6_i/ ~~~ rent
i:,.:.... - t..~.:.
